AVAC provides a rundown of news and presentations so far from the HIV Research For Prevention conference underway in Chicago.
One of the most promising candidates for future PrEP is a small molecule, highly potent NRTI EFdA, for which limited data have been presented, mostly in animals. Simon Collins reports.
"I will continue to say that using PrEP is protective against getting HIV and there are no guarantees," says Robert Grant, M.D., who says he is focused on making access and use of PrEP and HIV treatment easier.
Simon Collins provides more insight into the widely reported second confirmed case of HIV infection in a person who was adherent to PrEP.
Ten Years After Landmark HIV Testing Guidelines, How Are We Doing? Specifically in Emergency Departments?
"A lot has changed with HIV testing since the late 1990s, most notably the landmark CDC HIV testing guidelines, issued almost exactly 10 years ago today," Paul Sax, M.D., writes.
Paul Sax, M.D., provides a brief rundown of important prevention, treatment and complications research presented at the International AIDS Conference, and whatever else happened to catch his eye.
"I have profound memories of the 13th International AIDS Conference in Durban, South Africa," Chikwe Ihekweazu writes. "For me, it was a turning point. I realised that HIV/AIDS would be the most significant disease in my professional life."
"Just as we consider the National HIV/AIDS Strategy's anniversary as a time to assess progress and accomplishments, we can use the return to Durban as a time to reflect on how far we've come since 2000, how far we have yet to go and how we'll get the...
Tonya Taylor, Ph.D., a specialist in sexual health, walks us through the changes and challenges that can affect women of color who are aging with HIV or become positive later in life.
Emily Newman asks, "What do we lose by freeing ourselves from the word AIDS -- or, what might we have to gain?"